gentamicin has been researched along with Gram-Negative Bacterial Infections in 130 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Gram-Negative Bacterial Infections: Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the impact of an antimicrobial stewardship (AMS) intervention, involving introduction of new guidelines on the treatment of febrile neutropenia (FN), on improving the use of gentamicin in paediatric oncology patients." | 9.27 | Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia. ( Bialkowski, S; Clark, J; Consuelo Llanos Paez, C; Hennig, S; Lawson, R; Natanek, D; Staatz, CE, 2018) |
| "In a prospective multicentre open trial, hospitalised adult patients with acute lower respiratory tract infections, mainly pneumonia or bronchitis, were randomised to receive either isepamicin 8 or 15 mg/kg once daily depending on the severity of the infection or amikacin 7." | 9.08 | Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms. ( Covi, M; Velluti, G, 1995) |
| "The efficacy of aztreonam in combination with vancomycin was compared with that of gentamicin plus piperacillin as empirical antibiotic treatment for fever in 61 neutropenic patients." | 9.07 | Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study. ( Kelsey, SM; Newland, AC; Shaw, E, 1992) |
| "Because of the rapid emergence of resistance to gentamicin and tobramycin among isolates of aerobic and facultative gram-negative bacteria at our university hospital, we designed a prospective study to track aminoglycoside resistance, bacteremic episodes, and bacteremia-associated deaths before and after the institution of amikacin as the sole formulary aminoglycoside." | 7.68 | Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. ( Conrad, SA; King, JW; Todd, JR; White, MC, 1992) |
| "To evaluate the impact of an antimicrobial stewardship (AMS) intervention, involving introduction of new guidelines on the treatment of febrile neutropenia (FN), on improving the use of gentamicin in paediatric oncology patients." | 5.27 | Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia. ( Bialkowski, S; Clark, J; Consuelo Llanos Paez, C; Hennig, S; Lawson, R; Natanek, D; Staatz, CE, 2018) |
| "In a prospective multicentre open trial, hospitalised adult patients with acute lower respiratory tract infections, mainly pneumonia or bronchitis, were randomised to receive either isepamicin 8 or 15 mg/kg once daily depending on the severity of the infection or amikacin 7." | 5.08 | Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms. ( Covi, M; Velluti, G, 1995) |
| "Fifty children aged 3 months--16 y with Gram-negative bacterial infections, were evaluated in this open randomized study; 26 received gentamicin 4." | 5.08 | Gentamicin once-daily versus thrice-daily in children. ( Elhanan, K; Raz, R; Siplovich, L, 1995) |
| "The efficacy of aztreonam in combination with vancomycin was compared with that of gentamicin plus piperacillin as empirical antibiotic treatment for fever in 61 neutropenic patients." | 5.07 | Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study. ( Kelsey, SM; Newland, AC; Shaw, E, 1992) |
| " Gentamicin has comparable efficacy to mupirocin for peritonitis and gram-positive exit-site infection." | 4.98 | Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis. ( Cheng, SP; Hsu, YC; Liu, CL; Tsai, CC; Wu, CJ; Yang, PS, 2018) |
| "The aim of this study was to describe the safety profile and pharmacokinetic/pharmacodynamic parameters in end-stage renal disease patients who received gentamicin as empirical treatment in catheter-related bacteremia when they showed infection signs, regardless of the timing of the next HD." | 3.91 | Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics. ( Camacho-Martínez, P; Gil-Navarro, MV; Gil-Sacaluga, L; Guisado-Gil, AB; Herrera-Hidalgo, L; Lepe-Jiménez, JA; Molina, J; Santos-Rubio, MD, 2019) |
| " The majority of gram-negative bacterial infections were multidrug resistant, but 17 of the 20 gram-negative bacteria were sensitive to meropenem." | 3.81 | Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population. ( Albright, AL; Ferson, S; Ochieng', N; Okechi, H, 2015) |
| "This prospective, comparative study was designed to estimate the volume of distribution (Vd) and elimination rate constant (K(e)) of gentamicin and to determine the clinical factors affecting the pharmacokinetics of gentamicin in different stages of sepsis." | 3.70 | Factors affecting gentamicin pharmacokinetics in septic patients. ( Kong, CW; Lee, TY; Lin, BS; Tang, GJ; Tang, JJ, 1999) |
| "Almost 30 years after its introduction, gentamicin continues to play a key role in the treatment of gram negative sepsis." | 3.69 | Gentamicin once a day. ( MacConnachie, AM, 1996) |
| "Because of the rapid emergence of resistance to gentamicin and tobramycin among isolates of aerobic and facultative gram-negative bacteria at our university hospital, we designed a prospective study to track aminoglycoside resistance, bacteremic episodes, and bacteremia-associated deaths before and after the institution of amikacin as the sole formulary aminoglycoside." | 3.68 | Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. ( Conrad, SA; King, JW; Todd, JR; White, MC, 1992) |
| " Doctors feared inducing toxicity in patients, but limited the dose rather than altering the dosing interval according to renal function." | 2.80 | Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines? ( Baysari, M; Day, RO; Diasinos, N; Kumar, S, 2015) |
| " Single daily dosing with GM, regardless of the total daily dose, produced less nephrotoxicity than multiple dosing." | 2.74 | A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. ( Sweileh, WM, 2009) |
| "Gentamicin use was a significant predictor of lower peritonitis rates (relative risk, 0." | 2.71 | Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. ( Bender, F; Bernardini, J; Florio, T; Fried, L; Palmmontalbano, L; Piraino, B; Sloand, J, 2005) |
| "The results of our study indicated that once daily dosing of gentamycin was superior to multiple daily dosing in treating the lower respiratory tract infection in the study population." | 2.71 | Evaluation of target concentration intervention strategy of gentamicin therapy in a malnourished patient population of south India. ( Karthikeyan, VP; Rajendran, SD; Rao, YM, 2005) |
| "Netilmicin also was more effective than gentamicin in eradicating infections (p = 0." | 2.70 | Treatment of acute bacterial conjunctivitis with topical netilmicin. ( Aragona, P; Blanco, AR; Di, BA; Milazzo, G; Papa, V; Santocono, M; Scuderi, AC; Zola, P, 2002) |
| " A once daily dosing regimen of gentamicin is more effective and less ototoxic than a thrice daily regimen." | 2.68 | Intravenous administration of gentamicin once daily versus thrice daily in adults. ( Adawi, M; Raz, R; Romano, S, 1995) |
| " Therefore, in adult patients with a wide range of infections requiring aminoglycoside therapy, once-daily dosing with isepamicin is as effective as twice- daily dosing with amikacin." | 2.68 | Overview of the efficacy of isepamicin in the adult core clinical trial programme. ( Carbon, C, 1995) |
| " The proportion of patients experiencing at least one adverse event was 11%, 25% and 9% for isepamicin once daily, isepamicin twice daily and amikacin, respectively." | 2.68 | Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia. ( Beaucaire, G, 1995) |
| " Adverse events were reported in 12% of patients in the isepamicin group and 6% in the amikacin group." | 2.68 | Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections. ( Esparza-Ahumada, S; Morfin-Otero, R; Rodriguez-Noriega, E, 1995) |
| " Fourteen per cent of isepamicin and 11% of amikacin patients experienced adverse events." | 2.68 | The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection. ( Colardyn, F, 1995) |
| "Isepamicin is a new aminoglycoside with in-vitro activity superior to amikacin." | 2.68 | Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. ( Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C, 1995) |
| "The cause of bacterial meningitis is changing and first-line antimicrobial therapy and adjuvant therapies are evaluated." | 2.52 | Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress. ( Dube, Q; Molyneux, EM; Newberry, L, 2015) |
| " Conversely paediatric studies have shown lower rates and extended interval dosing may have reduced toxicity further." | 2.50 | Aminoglycoside toxicity in neonates: something to worry about? ( Heath, PT; Kent, A; Sharland, M; Turner, MA, 2014) |
| " The standard daily dosing (SDD) in infants and children is twice or three times daily depending on age." | 2.41 | Once daily dosing of gentamicin in infants and children. ( Miron, D, 2001) |
| "Gentamicin is an aminoglycoside antibiotic used in the treatment of gram-negative infections." | 2.38 | A review of gentamicin use in neonates. ( Fisk, KL, 1993) |
| "Ampicillin resistance was found in 113 cases (95%), cefotaxime 104 (87%), gentamicin 101 (85%), AmpGen 101 (85%), piperacillin-tazobactam 47 (39%), amikacin 10 (8." | 1.62 | Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis. ( Abayneh, M; Akeju, O; Ambachew, R; Bekele, D; Carvalho, MJ; Chan, GJ; Gebreyohannes, Z; Goddard, FGB; Metaferia, G; Milton, R; Odumade, OA; Sands, K; Solomon, S; Thomson, K; Van Wickle, K; Walsh, TR, 2021) |
| "Septicemia is one of the most fulminant forms, but diagnosis of C." | 1.51 | Infective endocarditis caused by Capnocytophaga canimorsus; a case report. ( Imanaka, K; Kawamura, T; Kodana, M; Maesaki, S; Matsuoka, T; Nishida, Y; Ohgane, K; Ohno, H; Oka, H; Sakai, J; Sekine, S; Yamamoto, K, 2019) |
| " In conclusion, gentamicin is safe and has similar outcomes to alternative Gram-negative antimicrobial regimens for empirical coverage in severe CAP patients admitted to the ICU." | 1.48 | Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study. ( Brereton, CJ; Browning, S; Davis, JS; Dunn, E; Ferguson, JK; Lennon, D, 2018) |
| "However, coinfection is rarely described and its occurrence frequency is unknown." | 1.48 | Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report. ( Andrianaivoarimanana, V; Bertherat, E; Rajaonarison, R; Rajerison, M; Rakotondramaro, T; Rogier, C, 2018) |
| "In liver transplant (LT) recipients, surgical site infection (SSI) represents an important cause of morbidity and mortality." | 1.43 | Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients. ( Abelleira, M; Castelli, J; Etlin, A; Gerona, S; González, LS; Grecco, G; Harguindeguy, M; Iglesias, C; Leites, A; López, M; Medina, JC; Menéndez, J; Prieto, J; Rando, K; Scalone, P; Valverde, M, 2016) |
| "Yet, isepamicin was active against 29." | 1.38 | Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance. ( Falagas, ME; Georgantzi, GG; Kofteridis, DP; Maraki, S; Samonis, G; Vouloumanou, EK, 2012) |
| "Isepamicin is a newly introduced aminoglycoside in Taiwan." | 1.34 | In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections. ( Chang, SC; Feng, NH; Hsueh, PR; Tsai, TY; Wang, JT, 2007) |
| " Standard treatment included a two-stage procedure involving externalization of the ventricular catheter in combination with intraventricular and systemic administration of antibiotic medication followed by shunt replacement." | 1.34 | Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections. ( Arnell, K; Enblad, P; Sjölin, J; Wester, T, 2007) |
| " The optimized population model allowed us to simulate gentamicin serum levels and their variability, in this kind of patient, when extended-interval dosage administration regimens were implemented." | 1.32 | Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. ( Calvo, MV; Carbajosa, MT; Domínguez-Gil, A; Lanao, JM; Martín-Suárez, A; Mesa, JA; Miguelez, F, 2004) |
| "Severe thrombocytopenia is a life-threatening condition." | 1.32 | Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. ( Arnold, DM; Christjanson, L; Smaill, F; Walker, I; Warkentin, TE, 2004) |
| " All of the pharmacokinetic parameters of interest were determined using Bayesian pharmacokinetic procedures and only two plasma gentamicin concentrations." | 1.32 | Bayesian pharmacokinetics of gentamicin in a haemodialysis population. ( Ariano, RE; Vercaigne, LM; Zacharias, JM, 2004) |
| "Respiratory tract infections were the commonest source of infection, and were associated with ventilator therapy rather than the underlying medical condition." | 1.30 | Survey of aerobic bacterial infections in paediatric surgical intensive care unit patients. ( Tan, CE; Tan, ML; Yap, KP, 1998) |
| "Cefazolin was equivalent to vancomycin for empiric treatment of clinically significant infections in a population with a low rate of methicillin-resistant Staphylococcus aureus infection." | 1.30 | Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. ( Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB, 1998) |
| " Specific physiologic criteria of sepsis may be used to identify critically ill patients who will most likely benefit from aggressive initial aminoglycoside dosing when these drugs are used to treat gram-negative infections." | 1.30 | Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis. ( Asensio, JA; Belzberg, H; Berne, TV; Cornwell, EE; Demetriades, D; Henriques, G; Kern, JW, 1997) |
| "The performance of dosage guidelines for starting gentamicin therapy was evaluated prospectively in 50 patients with suspected or proven Gram-negative septicaemia and the results were compared with results from similar group of 50 patients for whom the guidelines were not followed." | 1.29 | Antimicrobial practice. Development of guidelines for gentamicin dosing. ( Alcock, S; Duncan, N; Jodrell, D; Silverstein, B; Thomson, AH, 1996) |
| "Fifty-four surgical/trauma patients who had Gram-negative sepsis." | 1.29 | Physiologic response of stress and aminoglycoside clearance in critically ill patients. ( Cerra, FB; Miller, TQ; Shikuma, LR; Tholl, DA; Woodward, JM; Zaske, DE, 1993) |
| " Given the disparity among various in vitro susceptibility methods, this study incorporated a unique pharmacodynamic model to more accurately characterize the bacterial time-kill curves and mutation rates of four clinical isolates of S." | 1.29 | Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. ( Anderson, DE; Anderson, JD; Campbell, DM; Carroll, KC; Garrison, MW; Hollis, RJ; Malone, CL; Pfaller, MA, 1996) |
| "This study was designed to develop a population-specific dosing nomogram for gentamicin in medical intensive care unit (MICU) patients using the population pharmacokinetic program nonparametric expectation maximization (NPEM)." | 1.29 | Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram. ( Kisor, DF; Watling, SM, 1993) |
| "173 nontrachomatous conjunctivitis studied at the I." | 1.28 | [Tropical conjunctivitis: infectious etiology and validation of its clinical features]. ( Castan, R; Guillemot de Liniers, F; Huguet, P; Peyramaure, F; Resnikoff, S, 1991) |
| "Gentamicin was the most active antibiotic with ED50 values of 0." | 1.26 | The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin. ( Acred, P; Ryan, DM; Sowa, MA; Watts, CM, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.54) | 18.7374 |
| 1990's | 56 (43.08) | 18.2507 |
| 2000's | 37 (28.46) | 29.6817 |
| 2010's | 32 (24.62) | 24.3611 |
| 2020's | 3 (2.31) | 2.80 |
| Authors | Studies |
|---|---|
| Højgaard, SMM | 1 |
| Rezahosseini, O | 1 |
| Knudsen, JD | 1 |
| Fuglebjerg, NJU | 1 |
| Skov, M | 1 |
| Nielsen, SD | 1 |
| Harboe, ZB | 1 |
| Sakai, J | 1 |
| Imanaka, K | 1 |
| Kodana, M | 1 |
| Ohgane, K | 1 |
| Sekine, S | 1 |
| Yamamoto, K | 1 |
| Nishida, Y | 1 |
| Kawamura, T | 1 |
| Matsuoka, T | 1 |
| Maesaki, S | 1 |
| Oka, H | 1 |
| Ohno, H | 1 |
| Vidal-Veuthey, B | 1 |
| Jara, R | 1 |
| Santander, K | 1 |
| Mella, A | 1 |
| Ruiz, S | 1 |
| Collado, L | 1 |
| Solomon, S | 1 |
| Akeju, O | 1 |
| Odumade, OA | 1 |
| Ambachew, R | 1 |
| Gebreyohannes, Z | 1 |
| Van Wickle, K | 1 |
| Abayneh, M | 1 |
| Metaferia, G | 1 |
| Carvalho, MJ | 1 |
| Thomson, K | 1 |
| Sands, K | 1 |
| Walsh, TR | 1 |
| Milton, R | 1 |
| Goddard, FGB | 1 |
| Bekele, D | 1 |
| Chan, GJ | 1 |
| Tsai, CC | 1 |
| Yang, PS | 1 |
| Liu, CL | 1 |
| Wu, CJ | 2 |
| Hsu, YC | 1 |
| Cheng, SP | 1 |
| Marsicek, SM | 1 |
| Berman, D | 1 |
| Hennig, S | 1 |
| Staatz, CE | 1 |
| Natanek, D | 1 |
| Bialkowski, S | 1 |
| Consuelo Llanos Paez, C | 1 |
| Lawson, R | 1 |
| Clark, J | 1 |
| Brereton, CJ | 1 |
| Lennon, D | 1 |
| Browning, S | 1 |
| Dunn, E | 1 |
| Ferguson, JK | 1 |
| Davis, JS | 1 |
| Andrianaivoarimanana, V | 1 |
| Bertherat, E | 1 |
| Rajaonarison, R | 1 |
| Rakotondramaro, T | 1 |
| Rogier, C | 1 |
| Rajerison, M | 1 |
| Walker, O | 1 |
| Babb, C | 1 |
| Karampatsas, K | 1 |
| Richards, J | 1 |
| Kennea, N | 1 |
| Guisado-Gil, AB | 1 |
| Herrera-Hidalgo, L | 1 |
| Santos-Rubio, MD | 1 |
| Gil-Sacaluga, L | 1 |
| Molina, J | 1 |
| Lepe-Jiménez, JA | 1 |
| Camacho-Martínez, P | 1 |
| Gil-Navarro, MV | 1 |
| Padilla-Orozco, M | 1 |
| Mendoza-Flores, L | 1 |
| Herrera-Alonso, A | 1 |
| Garza González, E | 1 |
| Gutiérrez Ferman, JL | 1 |
| Rodríguez-López, JM | 1 |
| Bocanegra-Ibarias, P | 1 |
| Camacho-Ortiz, A | 1 |
| Manoraj, A | 1 |
| Thevanesam, V | 1 |
| Bandara, BMR | 1 |
| Ekanayake, A | 1 |
| Liyanapathirana, V | 1 |
| Weichman, KE | 1 |
| Levine, SM | 1 |
| Wilson, SC | 1 |
| Choi, M | 1 |
| Karp, NS | 1 |
| Chen, PL | 1 |
| Chen, CS | 1 |
| Tsai, PJ | 1 |
| Tang, HJ | 1 |
| Ko, WC | 1 |
| Kent, A | 1 |
| Turner, MA | 1 |
| Sharland, M | 1 |
| Heath, PT | 1 |
| Ducoulombier, V | 1 |
| Budzik, JF | 1 |
| Dehecq, E | 1 |
| Baclet, N | 1 |
| Houvenagel, E | 1 |
| Diasinos, N | 1 |
| Baysari, M | 1 |
| Kumar, S | 1 |
| Day, RO | 1 |
| Ochieng', N | 1 |
| Okechi, H | 1 |
| Ferson, S | 1 |
| Albright, AL | 1 |
| Molyneux, EM | 1 |
| Dube, Q | 1 |
| Newberry, L | 1 |
| Prior, FH | 1 |
| O'Hara, K | 1 |
| Whyte, IM | 1 |
| Prieto, J | 1 |
| Medina, JC | 1 |
| López, M | 1 |
| Rando, K | 1 |
| Iglesias, C | 1 |
| Harguindeguy, M | 1 |
| Leites, A | 1 |
| Etlin, A | 1 |
| Menéndez, J | 1 |
| Valverde, M | 1 |
| Scalone, P | 1 |
| Castelli, J | 1 |
| Grecco, G | 1 |
| Abelleira, M | 1 |
| González, LS | 1 |
| Gerona, S | 1 |
| Ereshefsky, BJ | 1 |
| Al-Hasan, MN | 1 |
| Gokun, Y | 1 |
| Martin, CA | 1 |
| Vecten, M | 1 |
| Martel, H | 1 |
| Casalta, JP | 1 |
| Hubert, S | 1 |
| Lepidi, H | 1 |
| Habib, G | 1 |
| Raoult, D | 1 |
| Gouriet, F | 1 |
| Le Meur, A | 1 |
| Albert, JD | 1 |
| Gautier, P | 1 |
| Ropars, M | 1 |
| Perdriger, A | 1 |
| Gando, N | 1 |
| Minet, J | 1 |
| Cormier, M | 1 |
| Bonnaure-Mallet, M | 1 |
| Jolivet-Gougeon, A | 1 |
| Nanayakkara, GM | 1 |
| Pethiyagoda, P | 1 |
| Jayasinghe, PN | 1 |
| Premachandra, U | 1 |
| Szeto, CC | 1 |
| Kwan, BC | 1 |
| Chow, KM | 1 |
| Law, MC | 1 |
| Pang, WF | 1 |
| Chung, KY | 1 |
| Leung, CB | 1 |
| Li, PK | 1 |
| Sweileh, WM | 1 |
| Acred, P | 1 |
| Ryan, DM | 1 |
| Sowa, MA | 1 |
| Watts, CM | 1 |
| Wardle, JK | 1 |
| Selkon, JB | 1 |
| Ingham, HR | 1 |
| Smith, A | 1 |
| Saiman, L | 1 |
| Zhou, J | 1 |
| Della-Latta, P | 1 |
| Jia, H | 1 |
| Graham, PL | 1 |
| Conde Rivera, O | 1 |
| Santos Nores, J | 1 |
| Borrajo Prol, M | 1 |
| Pérez Melón, C | 1 |
| Gupta, D | 1 |
| Green, J | 1 |
| Franco-Paredes, C | 1 |
| Lerakis, S | 1 |
| Tängdén, T | 1 |
| Enblad, P | 2 |
| Ullberg, M | 1 |
| Sjölin, J | 2 |
| Falagas, ME | 2 |
| Karageorgopoulos, DE | 1 |
| Georgantzi, GG | 2 |
| Sun, C | 1 |
| Wang, R | 1 |
| Rafailidis, PI | 1 |
| Turnidge, JD | 1 |
| Waterston, JA | 1 |
| Samonis, G | 1 |
| Maraki, S | 1 |
| Vouloumanou, EK | 1 |
| Kofteridis, DP | 1 |
| Shah, SS | 1 |
| Ohlsson, A | 2 |
| Shah, VS | 1 |
| Tsai, SF | 1 |
| Chen, CH | 1 |
| Shu, KH | 1 |
| Wu, MJ | 1 |
| Ogbolu, DO | 1 |
| Terry-Alli, OA | 1 |
| Daini, OA | 1 |
| Olabiyi, FA | 1 |
| Igharo, EA | 1 |
| Poi, MJ | 1 |
| Pisimisis, G | 1 |
| Barshes, NR | 1 |
| Darouiche, RO | 1 |
| Lin, PH | 1 |
| Kougias, P | 1 |
| Bechara, CF | 1 |
| Toltzis, P | 1 |
| Dul, MJ | 1 |
| Hoyen, C | 1 |
| Salvator, A | 1 |
| Walsh, M | 1 |
| Zetts, L | 1 |
| Toltzis, H | 1 |
| Amaya, RA | 1 |
| Edwards, MS | 1 |
| Flores, C | 1 |
| Maguilnik, I | 1 |
| Hadlich, E | 1 |
| Goldani, LZ | 1 |
| Rosenman, JR | 1 |
| Reynolds, JK | 1 |
| Kleiman, MB | 1 |
| Byington, CL | 1 |
| Rittichier, KK | 1 |
| Bassett, KE | 1 |
| Castillo, H | 1 |
| Glasgow, TS | 1 |
| Daly, J | 1 |
| Pavia, AT | 1 |
| Vercaigne, LM | 1 |
| Ariano, RE | 1 |
| Zacharias, JM | 1 |
| Lanao, JM | 1 |
| Calvo, MV | 1 |
| Mesa, JA | 1 |
| Martín-Suárez, A | 1 |
| Carbajosa, MT | 1 |
| Miguelez, F | 1 |
| Domínguez-Gil, A | 1 |
| Arnold, DM | 1 |
| Smaill, F | 1 |
| Warkentin, TE | 1 |
| Christjanson, L | 1 |
| Walker, I | 1 |
| Orsini, JA | 1 |
| Spencer, P | 1 |
| Shah, S | 1 |
| Shah, V | 1 |
| Haritova, AM | 1 |
| Djeneva, HA | 1 |
| Lashev, LD | 1 |
| Sotirova, PG | 1 |
| Gurov, BI | 1 |
| Dyankov, VN | 1 |
| Kaiser, AM | 1 |
| Schultsz, C | 1 |
| Kruithof, GJ | 1 |
| Debets-Ossenkopp, Y | 1 |
| Vandenbroucke-Grauls, C | 1 |
| Reshed'ko, GK | 1 |
| Sifakis, S | 1 |
| Angelakis, E | 1 |
| Makrigiannakis, A | 1 |
| Orfanoudaki, I | 1 |
| Christakis-Hampsas, M | 1 |
| Katonis, P | 1 |
| Tsatsakis, A | 1 |
| Koumantakis, E | 1 |
| Bernardini, J | 1 |
| Bender, F | 1 |
| Florio, T | 1 |
| Sloand, J | 1 |
| Palmmontalbano, L | 1 |
| Fried, L | 1 |
| Piraino, B | 1 |
| Qamruddin, AO | 1 |
| Alkawash, MA | 1 |
| Soothill, JS | 1 |
| Rajendran, SD | 1 |
| Rao, YM | 1 |
| Karthikeyan, VP | 1 |
| Jones, SL | 1 |
| Nguyen, VK | 1 |
| Nguyen, TM | 1 |
| Athan, E | 1 |
| Shivaprakasha, S | 1 |
| Radhakrishnan, K | 1 |
| Kamath, P | 1 |
| Karim, P | 1 |
| Alvarez, JR | 1 |
| Lamba, S | 1 |
| Dyer, KY | 1 |
| Apuzzio, JJ | 1 |
| Bolisetty, S | 1 |
| Agarwal, A | 1 |
| Arnell, K | 1 |
| Wester, T | 1 |
| Tsai, TY | 1 |
| Chang, SC | 1 |
| Hsueh, PR | 1 |
| Feng, NH | 1 |
| Wang, JT | 1 |
| Afshari, NA | 1 |
| Ma, JJ | 1 |
| Duncan, SM | 1 |
| Pineda, R | 1 |
| Starr, CE | 1 |
| Decroos, FC | 1 |
| Johnson, CS | 1 |
| Adelman, RA | 1 |
| Francetić, I | 1 |
| Kalenić, S | 1 |
| Huić, M | 1 |
| Mercep, I | 1 |
| Makar-Ausperger, K | 1 |
| Likić, R | 1 |
| Erdeljić, V | 1 |
| Tripković, V | 1 |
| Simić, P | 1 |
| García, DC | 1 |
| Woloj, GM | 1 |
| Piñeiro, S | 1 |
| Sordelli, DO | 1 |
| Kaufman, S | 1 |
| Raz, R | 2 |
| Adawi, M | 1 |
| Romano, S | 1 |
| Elhanan, K | 1 |
| Siplovich, L | 1 |
| Chenoweth, CE | 2 |
| Bradley, SF | 2 |
| Terpenning, MS | 2 |
| Zarins, LT | 1 |
| Ramsey, MA | 1 |
| Schaberg, DR | 1 |
| Kauffman, CA | 2 |
| Wan, JY | 1 |
| Jorgensen, KA | 1 |
| Carta, F | 1 |
| Pinna, A | 1 |
| Zanetti, S | 1 |
| Carta, A | 1 |
| Sotgiu, M | 1 |
| Fadda, G | 1 |
| Dryden, M | 1 |
| Eykyn, SJ | 1 |
| Alvarez, M | 1 |
| Mendoza, MC | 1 |
| Klein, JD | 1 |
| Eppes, SC | 1 |
| Fisk, KL | 1 |
| Tholl, DA | 1 |
| Shikuma, LR | 1 |
| Miller, TQ | 1 |
| Woodward, JM | 1 |
| Cerra, FB | 1 |
| Zaske, DE | 1 |
| Ismaeel, NA | 1 |
| Tayeri, T | 1 |
| Kelly, LD | 1 |
| Watling, SM | 1 |
| Kisor, DF | 1 |
| Sidhu, JS | 1 |
| Charles, BG | 1 |
| Triggs, EJ | 1 |
| Tudehope, DI | 1 |
| Gray, PH | 1 |
| Steer, PA | 1 |
| Herbrecht, R | 1 |
| Blaise, D | 1 |
| Espinouse, D | 1 |
| Leblond, V | 1 |
| Sadoun, A | 1 |
| Sauvage, C | 1 |
| Cordonnier, C | 1 |
| Minozzi, C | 1 |
| Colardyn, F | 1 |
| Covi, M | 1 |
| Velluti, G | 1 |
| Rodriguez-Noriega, E | 1 |
| Esparza-Ahumada, S | 1 |
| Morfin-Otero, R | 1 |
| Beaucaire, G | 1 |
| Carbon, C | 1 |
| Botha, P | 1 |
| Venter, M | 1 |
| Eisele, G | 1 |
| Bailie, GR | 1 |
| Kawula, TH | 1 |
| Lelivelt, MJ | 1 |
| Orndorff, PE | 1 |
| Domínguez, H | 1 |
| Vogel, BF | 1 |
| Gram, L | 1 |
| Hoffmann, S | 1 |
| Schaebel, S | 1 |
| Shapiro, DS | 1 |
| Brooks, PE | 1 |
| Coffey, DM | 1 |
| Browne, KF | 1 |
| Spraul, CW | 1 |
| Lang, GE | 1 |
| Lang, GK | 1 |
| Tan, DT | 1 |
| Lee, CP | 1 |
| Lim, AS | 1 |
| Miller, JM | 1 |
| Novy, C | 1 |
| Hiott, M | 1 |
| Thomson, AH | 1 |
| Duncan, N | 1 |
| Silverstein, B | 1 |
| Alcock, S | 1 |
| Jodrell, D | 1 |
| Stack, AM | 1 |
| Saladino, RA | 1 |
| Siber, GR | 1 |
| Thompson, C | 1 |
| Marra, MN | 1 |
| Novitsky, TJ | 1 |
| Fleisher, GR | 1 |
| Cornwell, EE | 1 |
| Belzberg, H | 1 |
| Berne, TV | 1 |
| Kern, JW | 1 |
| Henriques, G | 1 |
| Asensio, JA | 1 |
| Demetriades, D | 1 |
| Mastroianni, A | 1 |
| Coronado, O | 1 |
| Nanetti, A | 1 |
| Manfredi, R | 1 |
| Chiodo, F | 1 |
| MacConnachie, AM | 1 |
| Garrison, MW | 1 |
| Anderson, DE | 1 |
| Campbell, DM | 1 |
| Carroll, KC | 1 |
| Malone, CL | 1 |
| Anderson, JD | 1 |
| Hollis, RJ | 1 |
| Pfaller, MA | 1 |
| Richardson, JD | 1 |
| Kallová, J | 1 |
| Kettner, M | 1 |
| Macicková, T | 1 |
| Milosovic, P | 1 |
| Langsádl, L | 1 |
| Nettles, RE | 1 |
| Sexton, DJ | 1 |
| Palmer, LB | 1 |
| Smaldone, GC | 1 |
| Simon, SR | 1 |
| O'Riordan, TG | 1 |
| Cuccia, A | 1 |
| Schacht, J | 1 |
| Smith, K | 1 |
| Rindone, JP | 1 |
| Yap, KP | 1 |
| Tan, ML | 1 |
| Tan, CE | 1 |
| Raisis, AL | 1 |
| Hodgson, JL | 1 |
| Hodgson, DR | 1 |
| Fogel, MA | 1 |
| Nussbaum, PB | 1 |
| Feintzeig, ID | 1 |
| Hunt, WA | 1 |
| Gavin, JP | 1 |
| Kim, RC | 1 |
| Iwata, M | 1 |
| Tateda, K | 1 |
| Matsumoto, T | 1 |
| Furuya, N | 1 |
| Mizuiri, S | 1 |
| Yamaguchi, K | 1 |
| Hay, AJ | 1 |
| Lo, TY | 1 |
| Tang, GJ | 1 |
| Tang, JJ | 1 |
| Lin, BS | 1 |
| Kong, CW | 1 |
| Lee, TY | 1 |
| Alexandrakis, G | 1 |
| Alfonso, EC | 1 |
| Miller, D | 1 |
| Wilcox, RA | 1 |
| Chin, GK | 1 |
| Segasothy, M | 1 |
| Pession, A | 1 |
| Castellini, C | 1 |
| Prete, A | 1 |
| Locatelli, F | 1 |
| Urbini, B | 1 |
| Paolucci, G | 1 |
| Almuneef, MA | 1 |
| Baltimore, RS | 1 |
| Farrel, PA | 1 |
| Reagan-Cirincione, P | 1 |
| Dembry, LM | 1 |
| Kern, WV | 1 |
| Heiss, M | 1 |
| Steinbach, G | 1 |
| Tripodi, MF | 1 |
| Andreana, A | 1 |
| Sarnataro, G | 1 |
| Ragone, E | 1 |
| Adinolfi, LE | 1 |
| Utili, R | 1 |
| Miron, D | 1 |
| Papa, V | 1 |
| Aragona, P | 1 |
| Scuderi, AC | 1 |
| Blanco, AR | 1 |
| Zola, P | 1 |
| Di, BA | 1 |
| Santocono, M | 1 |
| Milazzo, G | 1 |
| Kim, JH | 1 |
| Kim, SW | 1 |
| Kang, HR | 1 |
| Bae, GB | 1 |
| Park, JH | 1 |
| Nam, EJ | 1 |
| Kang, YM | 1 |
| Lee, JM | 1 |
| Kim, NS | 1 |
| Miguélez, M | 1 |
| Domínguez-Ortega, L | 1 |
| del Palacio Medel, A | 1 |
| García Aguado, JM | 1 |
| Bateman, JM | 1 |
| Rainford, DJ | 1 |
| Masterton, RG | 1 |
| King, JW | 1 |
| White, MC | 1 |
| Todd, JR | 1 |
| Conrad, SA | 1 |
| Jensen, PD | 1 |
| Edgren, BE | 1 |
| Brundage, RC | 1 |
| Kelsey, SM | 1 |
| Shaw, E | 1 |
| Newland, AC | 1 |
| Castan, R | 1 |
| Resnikoff, S | 1 |
| Guillemot de Liniers, F | 1 |
| Huguet, P | 1 |
| Peyramaure, F | 1 |
| Toscano, MA | 1 |
| Minneci, M | 1 |
| Salmeri, M | 1 |
| Nicoletti, G | 1 |
| Cheadle, WG | 1 |
| Hanasawa, K | 1 |
| Gallinaro, RN | 1 |
| Nimmanwudipong, T | 1 |
| Kodama, M | 1 |
| Polk, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia: A Pilot Study[NCT02478710] | Phase 4 | 16 participants (Actual) | Interventional | 2015-06-30 | Terminated | ||
| Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653] | 150 participants (Anticipated) | Interventional | 2007-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for gentamicin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheter-Related Infections; | 2018 |
Aminoglycoside toxicity in neonates: something to worry about?
Topics: Amikacin; Aminoglycosides; Animals; Anti-Infective Agents; Drug-Related Side Effects and Adverse Rea | 2014 |
Improving the outcome of bacterial meningitis in newborn infants in Africa: reflections on recent progress.
Topics: Africa; Anti-Bacterial Agents; C-Reactive Protein; Drug Resistance, Bacterial; Female; Gentamicins; | 2015 |
Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Bibliographic; Drug Admi | 2012 |
Intraventricular antibiotics for bacterial meningitis in neonates.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Gentamicins; Gram-Negative Bacterial Infections; Huma | 2012 |
Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Female; Gentamicins; Gram-Negative Bacterial Infections; | 2012 |
Agrobacterium radiobacter bacteremia in pediatric patients: case report and review.
Topics: Bacteremia; Catheterization, Central Venous; Child; Device Removal; Drug Therapy, Combination; Femal | 2003 |
Capnocytophaga canimorsus meningitis in a newborn: an avoidable infection.
Topics: Ampicillin; Animals; Capnocytophaga; Cefotaxime; Dogs; Drug Therapy, Combination; Female; Follow-Up | 2003 |
Intraventricular antibiotics for bacterial meningitis in neonates.
Topics: Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Inj | 2004 |
A review of gentamicin use in neonates.
Topics: Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn | 1993 |
Aminoglycoside ototoxicity: prevention in sight?
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clinical Trials as Topic; Cochlea; Disease Mo | 1998 |
Once daily dosing of gentamicin in infants and children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cost-Benefit Analysis; Gentamicins; Gram | 2001 |
Two episodes of Stenotrophomonas maltophilia endocarditis of prosthetic mitral valve: report of a case and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Bioprosthesis; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bac | 2002 |
17 trials available for gentamicin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia.
Topics: Child; Child, Preschool; Febrile Neutropenia; Female; Gentamicins; Gram-Negative Bacteria; Gram-Nega | 2018 |
Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines?
Topics: Aged; Anti-Bacterial Agents; Decision Support Systems, Clinical; Dose-Response Relationship, Drug; D | 2015 |
A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Creatinine; Dose-Respon | 2009 |
Chemoprophylactic and bactericidal efficacy of 80 mg gentamicin in a single and once-daily dosing.
Topics: Adult; Amniotic Fluid; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cesarean Secti | 2005 |
Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Topics: Administration, Topical; Adult; Aged; Analysis of Variance; Catheters, Indwelling; Confidence Interv | 2005 |
Evaluation of target concentration intervention strategy of gentamicin therapy in a malnourished patient population of south India.
Topics: Adult; Anti-Bacterial Agents; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; | 2005 |
Intravenous administration of gentamicin once daily versus thrice daily in adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Monitoring; Female; G | 1995 |
Gentamicin once-daily versus thrice-daily in children.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Tolerance; Female; Gentamici | 1995 |
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplanta | 1995 |
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bronchitis; Ceftazidime; Cross Infection; Drug Admin | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Drug Administration Sch | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Sch | 1995 |
Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Female; Gen | 1995 |
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Fem | 1995 |
Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
Topics: Adult; Aerosols; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Case-Control Studies; Chr | 1998 |
Treatment of acute bacterial conjunctivitis with topical netilmicin.
Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Bacteria; Conjunctivitis, Bacterial; | 2002 |
Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
Topics: Adult; Aztreonam; Bacteremia; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacteria; | 1992 |
100 other studies available for gentamicin and Gram-Negative Bacterial Infections
| Article | Year |
|---|---|
Characteristics and Outcomes of Patients with Delftia acidovorans Infections: a Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Colistin; Delftia acidovorans; Female; | 2022 |
Infective endocarditis caused by Capnocytophaga canimorsus; a case report.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Bites and Stings; Blood Culture; Capnocytophaga; Ce | 2019 |
Antimicrobial resistance and virulence genes profiles of Arcobacter butzleri strains isolated from back yard chickens and retail poultry meat in Chile.
Topics: Animals; Anti-Bacterial Agents; Arcobacter; Chickens; Chile; Ciprofloxacin; Drug Resistance, Bacteri | 2021 |
Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ethiopia; F | 2021 |
Neonatal Bacteremia Caused by an Unusual Suspect.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Cefotaxime; Female; Gentamicins; Gram | 2017 |
Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infe | 2018 |
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacte | 2018 |
Screening for colonisation with gentamicin-resistant Gram-negative organisms on the neonatal unit: does positive screening predict sepsis?
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Negativ | 2019 |
Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Fema | 2019 |
Generalized and Prolonged Use of Gentamicin-Lock Therapy Reduces Hemodialysis Catheter-Related Infections Due to Gram Negatives.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Cohort | 2019 |
Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Synergism; Gentamicins; Gram-Negative Bacter | 2019 |
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Breast Implantation; Breast Implants; Devi | 2013 |
A comparative study of clinical Aeromonas dhakensis and Aeromonas hydrophila isolates in southern Taiwan: A. dhakensis is more predominant and virulent.
Topics: Adult; Aeromonas; Aged; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ceftriaxon | 2014 |
[Cardiobacterium hominis septic arthritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Cardiobacterium; Cervical Ver | 2014 |
Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Ciprofloxac | 2015 |
Best practice aminoglycoside monitoring.
Topics: Drug Monitoring; Drug Prescriptions; Female; Gentamicins; Gram-Negative Bacterial Infections; Guidel | 2015 |
Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients.
Topics: Administration, Cutaneous; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; A | 2016 |
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Critical Illness; | 2017 |
Fatal Neisseria macacae infective endocarditis: first report.
Topics: Abscess; Aged; Anti-Bacterial Agents; Aortic Valve; Ceftriaxone; Endocarditis, Bacterial; Fatal Outc | 2017 |
Acute tenosynovitis of the ankle due to Capnocytophaga cynodegmi/canimorsus as identified by 16S rRNA gene sequencing.
Topics: Abscess; Acute Disease; Administration, Oral; Ankle; Anti-Bacterial Agents; Capnocytophaga; Doxycycl | 2008 |
Chromobacterium violaceum infection in a provincial hospital in Sri Lanka.
Topics: Anti-Bacterial Agents; Bacteremia; Chromobacterium; Fatal Outcome; Gentamicins; Gram-Negative Bacter | 2008 |
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacte | 2009 |
The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
Topics: Agar; Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftazidime; Cephalosporin | 1981 |
Ceftazidime in Gram-negative infections: three case reports.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Fatal Outcome; Female; Gentamicins | 1981 |
Concordance of Gastrointestinal Tract Colonization and Subsequent Bloodstream Infections With Gram-negative Bacilli in Very Low Birth Weight Infants in the Neonatal Intensive Care Unit.
Topics: Anti-Bacterial Agents; Bacteremia; Cohort Studies; Female; Gastrointestinal Tract; Gentamicins; Gram | 2010 |
[Importance of exit site care as peritonitis prophylaxis: experience in our centre].
Topics: Administration, Topical; Antibiotic Prophylaxis; Candidiasis; Catheter-Related Infections; Catheters | 2010 |
Challenges in the clinical management of blood-culture negative endocarditis: case of Bartonella henselae infection.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve; Bartonella henselae; Cat-Scratch Disease | 2011 |
Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid; Drug Th | 2011 |
Gentamicin and ototoxicity: why this drug is still in use.
Topics: Anti-Bacterial Agents; Australia; Dose-Response Relationship, Drug; Gentamicins; Gram-Negative Bacte | 2012 |
Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negativ | 2012 |
Comparison of E-test with other conventional susceptibility testing methods for ciprofloxacin and gentamicin against gram negative enteric bacilli.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteri | 2012 |
Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections.
Topics: Administration, Topical; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antis | 2013 |
The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Mu | 2002 |
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Brazil; Cephalosporins; Cholangio | 2003 |
Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.
Topics: Ampicillin Resistance; Bacteremia; Bacterial Infections; Cefotaxime; Drug Resistance, Bacterial; Fev | 2003 |
Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Gentamicins; Gram-Negative Bacterial Infections; | 2004 |
Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Topics: Algorithms; Anti-Bacterial Agents; Bayes Theorem; Birth Weight; Gentamicins; Gram-Negative Bacterial | 2004 |
Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies.
Topics: Ampicillin; Antigens, Human Platelet; Aortic Valve Stenosis; Autoantibodies; Autoimmune Diseases; Ba | 2004 |
Epidemiology of aminoglycoside resistance in a large animal hospital.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial | 1997 |
Pharmacokinetics of gentamicin and apramycin in turkeys roosters and hens in the context of pharmacokinetic-pharmacodynamic relationships.
Topics: Animals; Cross-Over Studies; Drug Interactions; Escherichia coli; Female; Gentamicins; Gram-Negative | 2004 |
Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands.
Topics: Carrier State; Drug Resistance, Bacterial; Enterococcus; Gentamicins; Gram-Negative Bacteria; Gram-N | 2004 |
[Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacter | 2004 |
Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacter | 2005 |
Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Ciprofloxacin; Cross Infection; Dr | 2006 |
Late prosthetic valve endocarditis due to Cardiobacterium hominis, an unusual complication.
Topics: Anti-Bacterial Agents; Cardiobacterium; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacteria | 2007 |
An unusual case of urinary tract infection in a pregnant woman with Photobacterium damsela.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Female; Gentamicins; Gram-Negative Bacterial Infections; Hu | 2006 |
Subclinical kidney injury incites endotoxin hyperresponsiveness.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Endotoxins; Gentamicins; Gram-Negative Bacteria | 2007 |
Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
Topics: Adolescent; Anti-Bacterial Agents; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Gentamicins; | 2007 |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Gentamicins; Gram-Negative Bact | 2007 |
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Bacterial; Eye Infections, Bacteri | 2008 |
Impact of aminoglycoside cycling in six tertiary intensive care units: prospective longitudinal interventional study.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cost-Benefit Analysis; Croatia; Drug Resistance, M | 2008 |
An 8-year study of resistance to amikacin in gram-negative bacilli isolates from patients with nosocomial infection at one hospital in Argentina.
Topics: Acinetobacter; Amikacin; Argentina; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Ent | 1995 |
Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility.
Topics: Colony Count, Microbial; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; | 1994 |
Colonization and infection with antibiotic-resistant bacteria in a long-term care facility.
Topics: Aged; Bacterial Infections; Carrier State; Drug Resistance, Microbial; Enterococcus; Female; Gentami | 1994 |
Corneal ulcer caused by Aeromonas species.
Topics: Aeromonas hydrophila; Contact Lenses; Cornea; Corneal Ulcer; Eye Infections, Bacterial; Eye Injuries | 1994 |
Short-course gentamicin in gram-negative CAPD peritonitis.
Topics: Gentamicins; Gram-Negative Bacterial Infections; Humans; Peritoneal Dialysis, Continuous Ambulatory; | 1993 |
Molecular epidemiology of two genes encoding 3-N-aminoglycoside acetyltransferases AAC(3)I and AAC(3)II among gram-negative bacteria from a Spanish hospital.
Topics: Acetyltransferases; Blotting, Southern; DNA Probes; DNA, Bacterial; Drug Resistance, Microbial; Elec | 1993 |
Ochrobactrum anthropi bacteremia in a child.
Topics: Bacteremia; Ceftazidime; Child; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacter | 1993 |
Physiologic response of stress and aminoglycoside clearance in critically ill patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Blood Urea Nitrogen; Cross-Sectional St | 1993 |
Resistance of bacteria from human faecal flora to antimicrobial agents.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Child; Cross Infection; Drug Resi | 1993 |
Alcaligenes faecalis corneal ulcer in a patient with cicatricial pemphigoid.
Topics: Alcaligenes; Cefazolin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Gentami | 1993 |
Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram.
Topics: Adult; Aged; Aged, 80 and over; Female; Gentamicins; Gram-Negative Bacterial Infections; Hospitals, | 1993 |
Assessment of bioelectrical impedance for individualizing gentamicin therapy in neonates.
Topics: Electric Impedance; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Predic | 1993 |
Cardiobacterium hominis as a cause of bacterial endocarditis.
Topics: Adult; Anti-Bacterial Agents; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infectio | 1996 |
Successful treatment of Aeromonas hydrophila peritoneal dialysis-associated peritonitis using intermittent intraperitoneal gentamicin.
Topics: Aeromonas hydrophila; Aged; Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacterial Infections; | 1995 |
Using a new inbred fish model and cultured fish tissue cells to study Aeromonas hydrophila and Yersinia ruckeri pathogenesis.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Blotting, Southern; Cells, Cultured; Cyprinida | 1996 |
Shewanella alga bacteremia in two patients with lower leg ulcers.
Topics: Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Female; Gentamic | 1996 |
Peripartum bacteremia with CDC group HB-5 (Pasteurella bettyae).
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Female; Gentamicins; Gram-Negativ | 1996 |
Xanthomonas maltophilia keratitis associated with contact lenses.
Topics: Adult; Anti-Bacterial Agents; Contact Lenses; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye | 1996 |
Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Chloramphenicol Resistance; Cont | 1995 |
Case of bacterial endophthalmitis caused by an Agrobacterium radiobacter-like organism.
Topics: Aged; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Gentamicins; Gram-Negative Ba | 1996 |
Antimicrobial practice. Development of guidelines for gentamicin dosing.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Female; Gentamicins; Gram-Negative | 1996 |
A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Esch | 1997 |
Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; APACHE; Child; Female; Gentamicins; Gram-Negative Ba | 1997 |
Agrobacterium radiobacter pneumonia in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Ceftriaxone; Ce | 1996 |
Gentamicin once a day.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Gentamicins; Gram-Negative Bac | 1996 |
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clavulani | 1996 |
Failure to clear a Roseomonas line infection with antibiotic therapy.
Topics: Adult; Anti-Bacterial Agents; Catheterization, Central Venous; Ceftazidime; Drug Therapy, Combinatio | 1997 |
Aminoglycoside resistance. Enzymatic mechanisms in clinical bacterial strains in Slovakia during the last decade.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enzymes; Gentamicins; Gram-Negative Bacteria; Gra | 1997 |
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, C | 1997 |
A gentamicin order form improves its use.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arizona; Dose-Response Relationship, Drug; Drug Moni | 1998 |
Survey of aerobic bacterial infections in paediatric surgical intensive care unit patients.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacteria, Aerobic; Bacterial Infections; Child; Child, | 1998 |
Serum gentamicin concentrations in compromised neonatal foals.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Fluorescence Polarization Immunoassay; Gentamicins | 1998 |
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combina | 1998 |
Primary Shewanella alga septicemia in a patient on hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Escherichia coli; Female; G | 1999 |
Ochrobactrum anthropi meningitis in a pre-term neonate.
Topics: Alcaligenes; Cefotaxime; Cephalosporins; Female; Gentamicins; Gram-Negative Bacterial Infections; Hu | 1999 |
Factors affecting gentamicin pharmacokinetics in septic patients.
Topics: Aged; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; APACHE; Blood Urea Nitrog | 1999 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug R | 2000 |
Aeromonas hydrophila infection secondary to an electrical burn.
Topics: Aeromonas hydrophila; Aged; Anti-Infective Agents; Burns, Electric; Ciprofloxacin; Female; Gentamici | 2000 |
Method using urokinase and an antibiotic to avoid device removal in central venous catheter-related infections.
Topics: Adolescent; Anti-Bacterial Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Chi | 2000 |
Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; DNA, Bacterial; Drug Resistance | 2001 |
Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Comb | 2001 |
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Col | 2001 |
[Multiple pulmonary abscesses caused by Eikenella corrodens].
Topics: Adult; Cloxacillin; Eikenella corrodens; Gentamicins; Gram-Negative Bacterial Infections; Humans; Lu | 1992 |
Capnocytophaga canimorus infection and acute renal failure.
Topics: Acute Kidney Injury; Capnocytophaga; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; | 1992 |
Alterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside.
Topics: Amikacin; Bacteremia; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Negative | 1992 |
Population pharmacokinetics of gentamicin in neonates using a nonlinear, mixed-effects model.
Topics: Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Metabolic Clearance Rate; | 1992 |
[Tropical conjunctivitis: infectious etiology and validation of its clinical features].
Topics: Adenoviridae Infections; Adolescent; Adult; Case-Control Studies; Child; Conjunctivitis, Bacterial; | 1991 |
New epidemiological data on resistance to netilmicin and other aminoglycosides.
Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Gram-N | 1991 |
Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antithrombins; Benzamidines; End | 1991 |